1
Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:September 3, 2019Recruiting
Lymphoma, Mantle-Cell: 1030 Clinical Trials, Page 1 of 103
Hide Studies Not Open or Pending
2
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
Condition(s):Mantle Cell Lymphoma; LymphomaLast Updated:December 6, 2012Withdrawn
3
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Condition(s):Mantle Cell LymphomaLast Updated:October 16, 2019Not yet recruiting
4
Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.
Condition(s):Lymphoma, Mantle- CellLast Updated:May 14, 2013Completed
5
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice
Condition(s):Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-CellLast Updated:January 13, 2020Recruiting
6
A Disease Registry of Patients With Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:January 13, 2020Recruiting
7
Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:April 24, 2014Completed
8
Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Lymphoma, Mantle-cellLast Updated:January 24, 2017Completed
9
Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:February 28, 2019Active, not recruiting
10
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Condition(s):Lymphoma, Mantle CellLast Updated:December 20, 2019Recruiting